
    
      All participants will receive a single booster dose of Tdap vaccine (ADACELÂ®) on Day 0 and
      undergo immunogenicity assessment from blood samples provided prior to, and 28 days
      post-vaccination. Tolerability and safety will be monitored up to 28 days post-vaccination.
    
  